Tibet AIM Pharm. Inc.
SZSE:002826.SZ
10.97 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 15.726 | 46.116 | 43.473 | 41.091 | 37.329 | 25.255 | 60.477 | 55.358 | 50.03 | 33.857 | 21.823 |
| Afschrijvingen & Amortisatie
| 24.136 | 22.701 | 23.741 | 16.744 | 10.913 | 9.477 | 8.293 | 7.41 | 3.371 | 3.477 | 3.418 |
| Uitgestelde Inkomstenbelasting
| 1.298 | -2.682 | 3.553 | -3.643 | 1.187 | 1.14 | 1.925 | 0.648 | -3.038 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0.325 | 0.532 | 1.635 | 2.034 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 111.58 | 38.877 | 24.786 | 37.97 | 11.083 | -31.754 | 6.728 | -16.156 | -86.634 | -37.884 | 25.534 |
| Vorderingen
| 170.437 | 6.105 | 86.187 | -44.794 | -3.215 | -14.206 | -48.912 | -16.289 | -60.727 | -65.69 | 10.88 |
| Voorraden
| -13.416 | -12.088 | -12.518 | 8.778 | -0.939 | 5.501 | 1.686 | 8.685 | -16.384 | -2.412 | 3.083 |
| Crediteuren
| -46.74 | 47.542 | -52.436 | 77.629 | 14.05 | -24.19 | 52.03 | -9.2 | -6.484 | 0 | 0 |
| Overig Werkkapitaal
| 3.039 | -2.682 | 3.553 | -3.643 | 1.187 | -37.256 | 5.042 | -24.841 | -70.25 | -35.472 | 22.452 |
| Overige Niet-Contante Posten
| 2.957 | -36.883 | 13.436 | 7.938 | -3.344 | 10.336 | 1.79 | 10.567 | 3.541 | 2.734 | 1.465 |
| Kasstroom uit Operationele Activiteiten
| 166.881 | 68.453 | 109.522 | 101.736 | 59.202 | 13.314 | 77.288 | 57.179 | -29.691 | 2.184 | 52.24 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -3.181 | -3.198 | -25.195 | -38.429 | -170.451 | -67.716 | -74.616 | -18.522 | -44.172 | -45.122 | -28.616 |
| Netto Overnames
| 0.079 | 0.001 | -29.446 | 38.464 | 170.451 | 68.441 | 0.149 | 18.533 | 2.043 | 45.122 | 28.637 |
| Aankoop van Beleggingen
| -492.142 | -200 | -240 | -90 | -415 | -365 | -330 | -33 | -77.8 | -228.8 | -33.5 |
| Verkoop/verval van Beleggingen
| 452.242 | 201.481 | 240.907 | 120.547 | 386.08 | 368.532 | 332.874 | 33.037 | 80.064 | 212.605 | 16.529 |
| Overige Investeringsactiviteiten
| -39.821 | 0 | 0.057 | -38.429 | -170.451 | -67.716 | 0.81 | -18.522 | 1.901 | -45.122 | -28.616 |
| Kasstroom uit Investeringsactiviteiten
| -43.002 | -1.715 | -53.678 | -7.847 | -199.371 | -63.459 | -70.783 | -18.474 | -37.964 | -61.317 | -45.566 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| -39 | -50 | -40 | -140 | -40 | -40 | -10 | -60 | -10 | -20 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | -47.358 | 3.009 | 7.493 | 18.148 | 0 | -5.34 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -0.022 | -2.642 | -3.009 | -7.493 | -18.148 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -19.067 | -19.007 | -15.272 | -7.671 | -5.692 | -12.763 | -11.383 | -3.5 | -0.766 | -3.264 | -1.813 |
| Overige Financieringsactiviteiten
| -0.022 | 147.358 | -3.099 | 102.507 | 88.148 | 40 | -14.828 | 267.987 | 77.432 | 95 | 5 |
| Kasstroom uit Financieringsactiviteiten
| -59.303 | 27.592 | -59.203 | -46.781 | 39.748 | 27.237 | -26.211 | 204.487 | 66.666 | 71.736 | 3.187 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -0.003 | -0.018 | -0.018 | -0.078 | 0.032 | 0 | -0 | -0.018 | 0.009 | 0 | -0.004 |
| Netto Kasstroomverandering
| 64.573 | 94.312 | -3.377 | 47.029 | -100.388 | -22.909 | -19.706 | 243.174 | -0.981 | 12.603 | 9.857 |
| Kaspositie aan het Einde van de Periode
| 340.856 | 276.283 | 181.971 | 185.348 | 138.319 | 238.707 | 261.616 | 281.322 | 38.147 | 39.128 | 26.525 |